Oral alendronate in osteogenesis imperfecta

Indian Pediatrics

Volumn 42, Issue 11, 2005, Pages 1158-1160

  Unal, Edip ^a   Abaci, Ayhan ^a   Bober, Ece ^a   Buyukgebiz, Atilla ^a  

^a DOKUZ EYLUL UNIVERSITY   (Turkey)

Author keywords

Alendronate; Osteogenesis imperfecta

Indexed keywords

ALENDRONIC ACID; BISPHOSPHONIC ACID DERIVATIVE; BONE DENSITY CONSERVATION AGENT;

ANAMNESIS; ARTICLE; BONE DENSITY; CASE REPORT; CLINICAL FEATURE; FRACTURE; GROWTH CURVE; HUMAN; LONG BONE; MALE; MEDICAL EXAMINATION; OSTEOGENESIS IMPERFECTA; SCHOOL CHILD; CHILD; ORAL DRUG ADMINISTRATION;

ADMINISTRATION, ORAL; ALENDRONATE; BONE DENSITY CONSERVATION AGENTS; CHILD; HUMANS; MALE; OSTEOGENESIS IMPERFECTA;

EID: 33644692041     PISSN: 00196061     EISSN: 00196061     Source Type: Journal    
DOI: None     Document Type: Article

References (9)

1. Srivastava T, Alon US. The role of bisphosphonates in diseases of childhood. Eur J Pediatr 2003; 162: 735-751.
2. Falk MJ, Heeger S, Lynch KA, DeCaro KR, Bohach D, Gibson KS, et al. Intravenous bisphosphonate treatment in children with osteogenesis imperfecta. Pediatrics 2003; 111: 573-578.
3. Devogelaer JP. New uses of bisphosphonates: osteogenesis imperfecta. Curr Opin in Pharmacol 2002, 2: 748-753.
4. Glorieux FH, Bishop NJ, Plotkin H, Chabot G, Lanoue G, Travers R. Cyclic administration of pamidronate in children with severe osteogenesis imperfecta. N Engl J Med 1998; 339: 947-952.
5. Plotkin H, Rauch F, Bishop NJ, Montpetit K, Ruck-Gibis J, Travers R, et. al. Pamidronate treatment of severe osteogenesis imperfecta in children under 3 years of age. J Clin Endocrin & Metabol 2000; 85: 1846-1850.
6. Greulich WW, Pyle SI. 1959. Radiographic atlas of skeletal development of the hand and wrist. 2nd ed. Stanford, CA: Stanford University Press, 1998.
7. Sillence DO, Senn A, Danks DM. Genetic heterogeneity in osteogenesis imperfecta. J Med Genet 1979;16:101-116.
8. Bianchi ML, Cimaz R, Bardare M, Zulian F, Lepore L, Boncompagni A, et al. Efficacy and safety of alendronate for the treatment of osteoporosis in diffuse connective tissue diseases in children. Arthritis Rheumatism 2000; 43: 1960-1966.
9. Maasalu K, Haviko T, Martson A. Treatment of children with osteogenesis imperfecta in Estonia. Acta Pediatr 2003; 92:452-455.